Genetic Risk Score Correlates with Immune Profile and Risk of HCC and Cirrhosis development in Hispanics with MASLD

dc.catalogadordfo
dc.contributor.authorFu, Siyu
dc.contributor.authorGroothuismink, Anthonie
dc.contributor.authorBalderramo, Domingo
dc.contributor.authorMattos, Angelo Z.
dc.contributor.authorHoppe, Lisia
dc.contributor.authorCarrera, Enrique
dc.contributor.authorDiaz-Ferrer, Javier
dc.contributor.authorPrieto, Jhon
dc.contributor.authorBanales, Jesus M.
dc.contributor.authorArrese Jímenez, Marco Antonio
dc.contributor.authorHansen, Bettina E.
dc.contributor.authorBoonstra, Andre
dc.contributor.authorDebes, José D.
dc.date.accessioned2025-07-15T16:39:27Z
dc.date.available2025-07-15T16:39:27Z
dc.date.issued2025
dc.description.abstractGenetic risk score and immune dysregulations have been separately associated with the development of hepatocellular carcinoma (HCC) and cirrhosis in the context of metabolic associated steatotic liver disease (MASLD). Latin America has the highest prevalence of MASLD worldwide. However, the relationship between genetic risk scores, immune dysregulation and MASLD has not been explored.
dc.fechaingreso.objetodigital2025-07-15
dc.fuente.origenORCID
dc.identifier.doi10.1016/j.jhepr.2025.101508
dc.identifier.urihttps://doi.org/10.1016/j.jhepr.2025.101508
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/104929
dc.information.autorucEscuela de Medicina; Arrese Jimenez Marco Antonio; 0000-0002-0499-4191; 76095
dc.language.isoen
dc.nota.accesocontenido completo
dc.rightsacceso abierto
dc.rights.licenseAtribución/Reconocimiento 4.0 Internacional
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/deed.es
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.ods03 Good health and well-being
dc.subject.odspa03 Salud y bienestar
dc.titleGenetic Risk Score Correlates with Immune Profile and Risk of HCC and Cirrhosis development in Hispanics with MASLD
dc.typepreprint
sipa.codpersvinculados76095
sipa.trazabilidadORCID;2025-07-07
Files